Halozyme Therapeutics Inc (HALO)
38.88
-0.69
(-1.74%)
USD |
NASDAQ |
Sep 25, 15:59
38.90
+0.02
(+0.05%)
After-Hours: 20:00
Halozyme Therapeutics Price: 38.88 for Sept. 25, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2023 | 39.91 | 40.18 | 39.29 | 39.57 | 596516.0 |
| Sep 21, 2023 | 39.33 | 40.54 | 39.00 | 39.91 | 785675.0 |
| Sep 20, 2023 | 39.77 | 40.29 | 39.58 | 39.60 | 628936.0 |
| Sep 19, 2023 | 39.18 | 39.92 | 38.88 | 39.77 | 617104.0 |
| Sep 18, 2023 | 39.22 | 39.49 | 38.20 | 39.11 | 792330.0 |
| Sep 15, 2023 | 40.52 | 40.52 | 38.97 | 39.22 | 2.745M |
| Sep 14, 2023 | 41.42 | 41.61 | 40.38 | 40.52 | 939601.0 |
| Sep 13, 2023 | 38.82 | 41.50 | 38.82 | 41.03 | 1.300M |
| Sep 12, 2023 | 37.62 | 39.06 | 37.47 | 38.92 | 901603.0 |
| Sep 11, 2023 | 38.55 | 38.86 | 37.43 | 37.50 | 1.188M |
| Sep 08, 2023 | 39.11 | 39.39 | 38.29 | 38.51 | 980298.0 |
| Sep 07, 2023 | 40.94 | 41.92 | 39.08 | 39.14 | 1.016M |
| Sep 06, 2023 | 41.09 | 41.15 | 40.36 | 41.02 | 844956.0 |
| Sep 05, 2023 | 42.58 | 42.58 | 40.83 | 40.90 | 914241.0 |
| Sep 01, 2023 | 42.85 | 43.33 | 42.59 | 42.82 | 511359.0 |
| Aug 31, 2023 | 43.10 | 43.33 | 42.42 | 42.56 | 717120.0 |
| Aug 30, 2023 | 43.07 | 43.27 | 42.37 | 42.98 | 726621.0 |
| Aug 29, 2023 | 42.54 | 43.26 | 42.26 | 43.10 | 599635.0 |
| Aug 28, 2023 | 42.75 | 43.13 | 42.30 | 42.44 | 416691.0 |
| Aug 25, 2023 | 42.43 | 42.88 | 42.36 | 42.69 | 637157.0 |
| Aug 24, 2023 | 41.76 | 42.36 | 41.61 | 42.24 | 802177.0 |
| Aug 23, 2023 | 42.81 | 43.18 | 41.94 | 41.96 | 702553.0 |
| Aug 22, 2023 | 42.56 | 43.05 | 42.14 | 42.70 | 763485.0 |
| Aug 21, 2023 | 43.24 | 43.39 | 42.35 | 42.62 | 694788.0 |
| Aug 18, 2023 | 42.17 | 43.92 | 41.93 | 43.26 | 785802.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.33
Minimum
Dec 24 2018
59.44
Maximum
Dec 02 2022
32.57
Average
35.11
Median
Mar 04 2022
Price Benchmarks
| ViewRay Inc | 0.0086 |
| AIM ImmunoTech Inc | 0.518 |
| Perspective Therapeutics Inc | 0.2999 |
| Protalix BioTherapeutics Inc | 1.655 |
| Armata Pharmaceuticals Inc | 2.68 |
Price Related Metrics
| PE Ratio | 22.74 |
| PS Ratio | 6.913 |
| Price to Book Value | 33.96 |
| Price to Free Cash Flow | 18.27 |
| Earnings Yield | 4.40% |
| Market Cap | 5.129B |
| Operating PE Ratio | 17.47 |
| Normalized PE Ratio | 23.10 |